Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial

<p><i>Overall survival ratios of treatment group and control group.</i> Significantly better overall survival ratios were observed in treatment group than that in control group (<i>n</i>=90 per group,<i> P=</i>0.0353).</p>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial 

Figure 2 | Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled Trial 